December 14, 2022: NCHR supports CPSC’s plan to revise section ASTM F1004-22 of the mandatory standards for safety gates and enclosures to include a specific warning about the installation of wall cups. Gates and enclosures that use wall cups for mounting can break or unlatch if not installed properly which can result in falls, choking, and strangulations. A mandatory warning label that specifically addresses these concerns will alert parents to the need for proper installation of these gates and enclosures but we urge CPSC to make this mandatory label also present on the outside packaging of gates and enclosures.
Read More »We’re Speaking Out on Health Issues
NCHR scientists and health policy experts provide written and oral statements on a wide range of topics.
Here are many of the ways we have been Speaking Out on Health Policy Issues for the last few years. Whether the topic is legislation intended to cure diseases, proposed bans on BPA or other chemicals that disrupt your hormones, the importance of including women, people of color, and patients over 65 in clinical trials, or many other topics, you’ll gain a better understanding of our evidence-based analyses by reading these letters, statements, and testimony.
Here are the ways we have been Speaking out on Medical Treatments and Products, such as prescription drugs and medical devices that the FDA is considering approving, or is considering taking off the market because of serious risks. Whether the topic is Chantix, Addyi, Yaz, Essure, or medical products you’ve never heard of, you can find out more about what is known and not known about the safety and effectiveness of a wide range of products by looking through this section of our website.
NCHR’s Comment on the Draft IRIS Assessment Plan and Protocol for Assessing Cancer Risk from Inhalation Exposure to Cobalt and Cobalt Compounds
NCHR supports the EPA’s decision to assess the risk for cancer from inhalation exposure to cobalt and cobalt compounds. Other health organizations recognize that cobalt is a likely human carcinogen based on animal studies, and it is important for the EPA to investigate if the same link extends to humans as well. An analysis of the evidence is needed to understand the upper-dose limit and how to prevent dangerous exposures to cobalt and cobalt compounds. By providing these results, we hope organizations create guidelines and requirements that the industry must follow to protect worker’s health and well-being of the public.
Read More »NCHR encourages WSPI to do more to prevent long-term impact of diabetes in pregnancy
December 8, 2022: The National Center for Health Research (NCHR) agrees with the Women’s Preventive Services Initiative (WPSI) 2022 recommendations for diabetes screening after pregnancy. WPSI encourages continued diligence during the postpartum period in patients who were diagnosed with diabetes mellitus during pregnancy. That’s important because gestational diabetes increases a patient’s chances of developing type 2 diabetes.
Read More »NCHR’s Comment on Topics Discussed in the Advancing Premarket Safety Analytics Workshop
NCHR had the opportunity to share our views with the Food and Drug Administration (FDA) about topics brought up in the Advancing Premarket Safety Analytics Workshop, including our support of the FDA Medical Queries as we believe it would better quantify adverse events. Additionally, we agree that the FDA should be transparent in providing their methods for the standard safety tables and figures via their integrated guide to the public and urge them to make these guidelines mandatory so that everyone is held to the same standard.
Read More »NCHR Comments on EPA Request for Information on Better Indoor Air Quality (IAQ) Management to Help Reduce COVID-19
December 5, 2022: Current IAQ standards are insufficient and poorly regulated at state and local levels to keep the public safe from increased COVID-19 transmission and other respiratory illnesses. Federal mandates would ensure that all indoor public spaces are properly assessed to improve ventilation rates. In the absence of greater regulation, the EPA must promote alternative methods of air filtration such as the Corsi-Rosenthal Box.
Read More »